Investing Ideas
/
Swedish Healthcare Undervalued Stocks Based On Cash Flows

Swedish Healthcare Undervalued Stocks Based On Cash Flows

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

1 new

Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.

9 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
SUS New Surgical Science Sweden	SEK 161.50	5.3%	-9.3%	SEK 8.2b	SEK 192.17	PE42.6x	E36.1%	n/a
EQL EQL Pharma	SEK 79.80	-4.3%	140.4%	SEK 2.3b	SEK 65.00	PE74.4x	E53.3%	n/a
MNTC Mentice	SEK 25.00	-4.2%	-44.1%	SEK 639.2m	SEK 42.67	PS2.3x	E116.7%	0%
XVIVO Xvivo Perfusion	SEK 466.50	-1.0%	46.7%	SEK 14.7b	SEK 538.17	PE71.9x	E23.0%	n/a
BACTI B Bactiguard Holding	SEK 37.70	12.2%	-39.4%	SEK 1.3b	SEK 55.00	PS5.6x	E100.0%	n/a
CARA Carasent	SEK 22.10	0.9%	n/a	SEK 1.6b	n/a	PS6.2x	E81.4%	8.1%
SYNT SyntheticMR	SEK 27.70	0%	-13.4%	SEK 1.2b	SEK 30.00	PE115.3x	E47.4%	0%
CEVI CellaVision	SEK 221.00	-2.4%	7.0%	SEK 5.3b	SEK 270.00	PE35.1x	E22.8%	1.0%
VIMIAN Vimian Group	SEK 42.10	3.8%	49.4%	SEK 22.0b	SEK 48.03	PE7478.5x	E89.8%	n/a

Page 1 of 1